Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H6O4 |
| Molecular Weight | 154.1201 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC(O)=CC=C1O
InChI
InChIKey=WXTMDXOMEHJXQO-UHFFFAOYSA-N
InChI=1S/C7H6O4/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,8-9H,(H,10,11)
| Molecular Formula | C7H6O4 |
| Molecular Weight | 154.1201 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Gentisic acid is an active metabolite of salicylic acid degradation, which possesses a broad spectrum of biological activity, such as anti-inflammatory, antirheumatic and antioxidant properties. The antioxidant activity and radioprotective properties of gentisic acid are exerted by its phenoxyl group. It is also used in cosmetics as a skin-whitening agent for the treatment of skin pigmentary disorders by influencing the synthesis of melanin through inhibition of melanosomal tyrosinase activity Gentisic acid is also a biomarker of Renal Cell Carcinoma.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P14679 Gene ID: 7299.0 Gene Symbol: TYR Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/12594007 |
|||
Target ID: free radical Sources: https://www.ncbi.nlm.nih.gov/pubmed/22023109 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Determination of hydroxyl radical by capillary zone electrophoresis with amperometric detection. | 2003-10-17 |
|
| Different antioxidant effects of polyphenols on lipid peroxidation and hydroxyl radicals in the NADPH-, Fe-ascorbate- and Fe-microsomal systems. | 2003-10-01 |
|
| Phospholipase A2, hydroxyl radicals, and lipid peroxidation in transient cerebral ischemia. | 2003-10 |
|
| Isolation of free phenolic compounds from arboreal leaves by use of the Florisil/C18 system. | 2003-10 |
|
| Ascorbic acid: useful as a buffer agent and radiolytic stabilizer for metalloradiopharmaceuticals. | 2003-09-18 |
|
| Rate and extent of ion-exchange process: the effect of physico-chemical characteristics of salicylate anions. | 2003-09-04 |
|
| Evaluation of the quantitativeness of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry using an equimolar mixture of uniform poly(ethylene glycol) oligomers. | 2003-09 |
|
| Co-localization of brain-derived neurotrophic factor (BDNF) and wild-type huntingtin in normal and quinolinic acid-lesioned rat brain. | 2003-09 |
|
| Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases. | 2003-08-18 |
|
| Irradiation effects in MALDI, ablation, ion production, and surface modifications. Part II. 2,5-dihydroxybenzoic acid monocrystals. | 2003-08 |
|
| Combined effects of electrostatic and pi-pi stacking interactions: selective binding of nucleotides and aromatic carboxylates by platinum(II)-aromatic ligand complexes. | 2003-07-21 |
|
| Molecular characterization of an inducible gentisate 1,2-dioxygenase gene, xlnE, from Pseudomonas alcaligenes NCIMB 9867. | 2003-07-17 |
|
| Lithium treatment induces a hypersensitive-like response in tobacco. | 2003-07 |
|
| Two-laser infrared and ultraviolet matrix-assisted laser desorption/ionization. | 2003-07 |
|
| Determination of hydroxyl radical by capillary electrophoresis and studies on hydroxyl radical scavenging activities of Chinese herbs. | 2003-07 |
|
| Antibacterial xanthones from Kielmeyera variabilis mart. (Clusiaceae). | 2003-06 |
|
| Quinaprilat reduces myocardial infarct size involving nitric oxide production and mitochondrial KATP channel in rabbits. | 2003-06 |
|
| Defibrillatory action of glibenclamide is independent from ATP-sensitive K+ channels and free radicals. | 2003-06 |
|
| Photosynthetic responses of corn and soybean to foliar application of salicylates. | 2003-05 |
|
| Postischemic hypothermia inhibits the generation of hydroxyl radical following transient forebrain ischemia in rats. | 2003-05 |
|
| Tempol, a novel stable nitroxide, reduces brain damage and free radical production, after acute subdural hematoma in the rat. | 2003-04 |
|
| Comparison of laser desorption and matrix-assisted laser desorption/ionization for ruthenium and osmium trisbipyridine complexes using Fourier transform mass spectrometry. | 2003-04 |
|
| Non-steroidal anti-inflammatory drug sodium salicylate, but not diclofenac or celecoxib, protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. | 2003-03-21 |
|
| Fluorinated matrix approach for the characterization of hydrophobic perfluoropolyethers by matrix-assisted laser desorption/ionization time-of-flight MS. | 2003-03-15 |
|
| Aromatic trap analysis of free radicals production in experimental collagen-induced arthritis in the rat: protective effect of glycosaminoglycans treatment. | 2003-03 |
|
| Nickel-induced oxidative stress and effect of antioxidants in human lymphocytes. | 2003-03 |
|
| Effects of phenolic acids on human phenolsulfotransferases in relation to their antioxidant activity. | 2003-02-26 |
|
| In vitro evaluation of patch formulations for topical delivery of gentisic acid in rats. | 2003-02 |
|
| Attenuation of methamphetamine induced dopaminergic neurotoxicity by flupirtine: microdialysis study on dopamine release and free radical generation. | 2003-02 |
|
| Patterned monolayer/polymer films for analysis of dilute or salt-contaminated protein samples by MALDI-MS. | 2003-01-15 |
|
| Matrix-assisted laser desorption/ionization analysis of lipids and high molecular weight hydrocarbons with lithium 2,5-dihydroxybenzoate matrix. | 2003 |
|
| Sample preparation effects in matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry of partially depolymerised carboxymethyl cellulose. | 2003 |
|
| Some aspects of the stability of ion current in a matrix-assisted laser desorption/ionization source. | 2003 |
|
| Analysis of a bioactive beta-(1 --> 3) polysaccharide (Curdlan) using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | 2003 |
|
| Ionic matrices for matrix-assisted laser desorption/ionization time-of-flight detection of DNA oligomers. | 2003 |
|
| Sample depletion of the matrix-assisted laser desorption process monitored using radionuclide detection. | 2002-12-15 |
|
| Internal energy of ions generated by matrix-assisted laser desorption/ionization. | 2002-12-15 |
|
| Laser desorption/ionization time-of-flight mass spectrometry on sol-gel-derived 2,5-dihydroxybenzoic acid film. | 2002-11-15 |
|
| [Analysis of aromatic hydrocarbon catabolic genes in strains isolated from soil in Patagonia]. | 2002-11-06 |
|
| Ionization energy reductions in small 2,5-dihydroxybenzoic acid-proline clusters. | 2002-11 |
|
| Matrix-assisted ultraviolet laser-desorption ionization and electrospray-ionization time-of-flight mass spectrometry of sulfated neocarrabiose oligosaccharides. | 2002-09-27 |
|
| Solid phase microextraction with matrix assisted laser desorption/ionization introduction to mass spectrometry and ion mobility spectrometry. | 2002-09 |
|
| Factors governing the solubilization of phosphopeptides retained on ferric NTA IMAC beads and their analysis by MALDI TOFMS. | 2002-09 |
|
| A quantitative model of ultraviolet matrix-assisted laser desorption/ionization. | 2002-08 |
|
| Sheng-Mai-San is protective against post-ischemic myocardial dysfunction in rats through its opening of the mitochondrial KATP channels. | 2002-08 |
|
| Anti-HSV-1 activity of synthetic humic acid-like polymers derived from p-diphenolic starting compounds. | 2002-07 |
|
| Rapid analysis of intact phospholipids from whole bacterial cells by matrix-assisted laser desorption/ionization mass spectrometry combined with on-probe sample pretreatment. | 2002 |
|
| Mass spectrometric studies of benzoxazine resorcarenes. | 2002 |
|
| Small angle neutron scattering measurements of synthetic polymer dispersions in matrix-assisted laser desorption/ionization matrixes. | 2002 |
|
| [Determination of salicylic acid and its hydroxylated products using high performance liquid chromatography and fluorescence detection]. | 2001-03 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12594007
in rats
Route of Administration:
Transdermal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/22023109
Antioxidant activity of gentisic acid has been studied using fast chemical kinetics and two in vitro models, namely the isolated rat liver mitochondria (RLM) and the human erythrocytes. The presence of gentisic acid (GA) during irradiation significantly reduced the levels of gamma radiation induced damages to lipids and proteins in RLM. GA efficiently scavenged hydroxyl radical (k = 1.1 × 10(10) dm(3)mol(-1)s(-1)) to produce reducing adduct radical (~76%) and oxidizing phenoxyl radical (~24%). GA has also scavenged organohaloperoxyl radical (k = 9.3 × 10(7) dm(3) mol(-1)s(-1)).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:54:34 GMT 2025
by
admin
on
Mon Mar 31 17:54:34 GMT 2025
|
| Record UNII |
VP36V95O3T
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
LOINC |
79515-3
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID4060078
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106782
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
VP36V95O3T
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
3469
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
m5703
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | Merck Index | ||
|
27224
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
3260
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
GENTISIC ACID
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
100000084521
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
756
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
VP36V95O3T
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
C010925
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
207-718-5
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107562
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
58044
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
SUB07895MIG
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
C76714
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
490-79-9
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
17189
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | |||
|
1368641
Created by
admin on Mon Mar 31 17:54:34 GMT 2025 , Edited by admin on Mon Mar 31 17:54:34 GMT 2025
|
PRIMARY | RxNorm |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
|
||
|
|
SALT/SOLVATE -> PARENT |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
Correction factors: for the calculation of contents, multiply the peak areas by 1.4
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|